KR880701556A - 아연을 함유한 카테콜 부탄의 조성물 - Google Patents

아연을 함유한 카테콜 부탄의 조성물

Info

Publication number
KR880701556A
KR880701556A KR1019880700742A KR880700742A KR880701556A KR 880701556 A KR880701556 A KR 880701556A KR 1019880700742 A KR1019880700742 A KR 1019880700742A KR 880700742 A KR880700742 A KR 880700742A KR 880701556 A KR880701556 A KR 880701556A
Authority
KR
South Korea
Prior art keywords
composition
containing zinc
butane containing
catechol butane
zinc
Prior art date
Application number
KR1019880700742A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR880701556A publication Critical patent/KR880701556A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019880700742A 1986-10-28 1988-06-28 아연을 함유한 카테콜 부탄의 조성물 KR880701556A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/924,620 US4880637A (en) 1985-02-11 1986-10-28 Compositions of catecholic butanes with zinc
PCT/US1987/002868 WO1988003026A1 (en) 1986-10-28 1987-10-27 Compositions of catecholic butanes with zinc

Publications (1)

Publication Number Publication Date
KR880701556A true KR880701556A (ko) 1988-11-03

Family

ID=25450444

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700742A KR880701556A (ko) 1986-10-28 1988-06-28 아연을 함유한 카테콜 부탄의 조성물

Country Status (8)

Country Link
US (1) US4880637A (ko)
EP (1) EP0288534B1 (ko)
JP (1) JPH01501794A (ko)
KR (1) KR880701556A (ko)
AT (1) ATE70449T1 (ko)
AU (1) AU616641B2 (ko)
DE (1) DE3775387D1 (ko)
WO (1) WO1988003026A1 (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003805A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
EP0750496A1 (en) * 1994-03-14 1997-01-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US6365787B1 (en) * 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6787573B2 (en) * 1999-07-02 2004-09-07 Universiteit Utrecht Antiviral therapy
US6608108B2 (en) * 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6214874B1 (en) 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
US7728036B2 (en) * 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
EP1631270A4 (en) * 2003-05-20 2007-11-14 Erimos Pharmaceutical Llp METHOD AND COMPOSITIONS FOR DISTRIBUTING CATECHOLIC BUTANES FOR THE TREATMENT OF DISEASES
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
RU2006140961A (ru) * 2004-05-28 2008-07-10 Юниджен Фармасьютикалз Диарилалканы в качестве эффективных ингибиторов двухъядерных ферментов
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
CA2595606C (en) * 2005-01-27 2014-12-16 Erimos Pharmaceuticals Llc Oral formulations for delivery of catecholic butanes including ndga compounds
CN101150956B (zh) * 2005-01-27 2013-04-17 埃里莫斯医药品有限公司 用于注射入动物的包括ndga化合物的儿茶酚丁烷配方
KR20090006062A (ko) * 2006-02-23 2009-01-14 에리모스 파마슈티컬스 엘엘씨 인플루엔자 바이러스 감염의 치료 방법
US20070212331A1 (en) * 2006-03-07 2007-09-13 Baldassare Joseph J Methods and compositions for selectively killing cells
US8178527B2 (en) * 2006-10-02 2012-05-15 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
US7597914B1 (en) * 2007-10-02 2009-10-06 Allen Jay Cohen Ala-septic pre-cancerous liquid dissolving solution and method
US8153171B1 (en) * 2007-10-02 2012-04-10 Allen Jay Cohen Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions
KR102397221B1 (ko) 2008-07-21 2022-05-12 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
KR102113823B1 (ko) 2011-03-24 2020-05-21 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404146A (en) * 1980-12-17 1983-09-13 Biosystems Research Inc. Metal oxyalkylates and method of making same
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
AU6330486A (en) * 1986-08-25 1988-03-24 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6737987A (en) * 1986-11-19 1988-06-16 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
AU8172487A (en) 1988-05-25
EP0288534A1 (en) 1988-11-02
EP0288534A4 (en) 1989-02-23
JPH01501794A (ja) 1989-06-22
ATE70449T1 (de) 1992-01-15
EP0288534B1 (en) 1991-12-18
AU616641B2 (en) 1991-11-07
US4880637A (en) 1989-11-14
WO1988003026A1 (en) 1988-05-05
DE3775387D1 (de) 1992-01-30

Similar Documents

Publication Publication Date Title
KR880701556A (ko) 아연을 함유한 카테콜 부탄의 조성물
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
ES491225A0 (es) Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
SE7611379L (sv) Antihypertensiva medel
GR1000392B (el) Σταθεροποιημενες συνθεσεις περιεχουσες επιδερμικο παραγοντα αναπτυξης.
ATE33635T1 (de) Substituierte sulfonamidbenzamide, antiarythmische mittel und deren zusammensetzungen.
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
IL64956A0 (en) Tetrahydronaphthalene and indane derivatives,their manufacture and pharmaceutical compositions containing them
ES510087A0 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
DE3785046A1 (ko)
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
SE8303732D0 (sv) Compositon for reducing sebum secretion
ATE53489T1 (de) Zusammensetzung zur behandlung von hauterkrankungen und ihre verwendung.
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ATE215810T1 (de) Abschuppungs-zusammensetzung
AR225286A1 (es) Nuevas composiciones cosmeticas para combatir el estado grasoso del cabello y de la piel;compuestos de n-(mercapto-2-etil)-beta-hidroxietilamina de aplicacion exclusiva en dichas composiciones y procedimiento para prepararlas
IE792418L (en) Diazines.
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
JPS5748915A (en) Tumor inhibiting pharmaceutical composition and use thereof
ES2088682T3 (es) Agente bronceador de la piel.
RU95100308A (ru) Способ лечения гнойно-некротических заболеваний пальцев у крупного рогатого скота по е.п.мажуге
JPS649906A (en) External drug for skin

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application